changing the growth conditions, these cells can then be coaxed to develop into many different cell types.
Until now, scientists have only been able to generate animal stem-cell lines from the reprogrammed nuclei of cells. "This is the first paper to convincingly show that you can get human reprogramming," says Robin Lovell-Badge, a cell biologist at the National Institute for Medical Research in London.
Sheng claims to have successfully reprogrammed cells from the foreskin tissues of males aged 5, 42 and 52 years and from the facial skin of a 60-year old woman. "It just goes to show that age doesn't matter," says Lovell-Badge.
But Sheng has had a tough time convincing some experts."I first submitted the paper more than two years ago," she says. It is understood that the paper was considered and rejected by other journals before this week's publication in China.
"I was frustrated that it took so long to get the paper published," Sheng says,"and it still may take a while for people to accept the work. But the scientific community has the right to question the details of the work and we have a responsibility to respond to them." Doug Melton a cell biologist at Harvard University, for one, has concerns about the "It would be very surprising if the cell lines were stable," Melton adds, noting that many interspecies hybrids are unstable, because of incompatibilities between the nucleus and mitochondria (the energyproducing compartments of cells) from different species.
And Rudolf Jaenisch, of the Whitehead Institute in Cambridge, Massachusetts, is not convinced that the derived cells meet the usual criteria for embryonic stem cells. "An important criterion is indefinite growth," he says."This is not shown."
But reservations aside, Melton is pleased that the work has finally seen the light of day. "I'm glad to see it published as it will encourage others to try it,"he says.
At this stage, Sheng has no plans to use stem cells created by her method to treat humans."It is a research tool. But there is the possibility that if it were proved to be safe enough for clinical use, it could provide a solution to human egg shortages for reprogramming in the future,"says Sheng.
While the scientific community debates her work, Sheng is keen to test the embryonic stem cells she has generated in an animal model. "It will be important to see whether they will be tolerated by the immune system and whether they can correct an animal model of human disease,"she says. 
